The Effects of Nicardipine and Esmolol Applied for Controlled Hypotension

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 12, 2022

Primary Completion Date

August 1, 2022

Study Completion Date

August 30, 2022

Conditions
HypotensionSurgery-ComplicationsOxygen Deficiency
Interventions
PROCEDURE

Controlled hypotention

"The procedure to be applied to the cases to be included in the study:~Patients randomized by the sealed envelope method will be divided into 2 groups (40 patients in each group).~The sealed envelopes that determine which group the patient will belong to will be randomly selected by the patient.~Standard general anesthesia will be applied to all patients. Before starting the surgical procedure; Group N (Nicardipine infusion) will be administered at a dose of 5-15mg/h, and Group E (Esmolol infusion) at a dose of 50-300mcg/kg/min.~2\) General anesthesia will be applied to all groups. Patients will be administered controlled hypotension (mean arterial pressure 50-60 mmHg)."

Trial Locations (1)

65080

Van yuzuncu Yıl University, Dursun Odabas Medical Center, Van

All Listed Sponsors
lead

Yuzuncu Yıl University

OTHER